Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment - Individual patient meta-analysis of 13,677 subjects

Boekholdt, S. et al. (2005) Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment - Individual patient meta-analysis of 13,677 subjects. Circulation, 111, pp. 278-287. (doi:10.1161/01.CIR.0000153341.46271.40)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Freeman, Dr Dilys and McMahon, Dr Alex
Authors: Boekholdt, S., Sacks, F., Jukema, J., Shepherd, J., Freeman, D., McMahon, A., Cambien, F., Nicaud, V., de Grooth, G., Talmud, P., Humphries, S., Miller, G., Eiriksdottir, G., Gudnason, V., Kauma, H., Kakko, S., Savolainen, M., Arca, M., Montali, A., Liu, S., and Lanz, H.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing > Clinical Specialities
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing > Dental School
Journal Name:Circulation

University Staff: Request a correction | Enlighten Editors: Update this record